Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis

Psychoneuroendocrinology

Volumn 36, Issue 10, 2011, Pages 1505-1512

  Kern, S ^a   Schultheiss T ^a   Schneider, H ^a   Schrempf, W ^a   Reichmann, H ^a   Ziemssen, T ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cortisol awakening response; Depression; HPA axis; Multiple sclerosis; Neurological impairment

Indexed keywords

HYDROCORTISONE;

ADULT; AROUSAL; ARTICLE; BECK DEPRESSION INVENTORY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; DEPRESSION; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; PITUITARY-ADRENAL SYSTEM; SALIVA; YOUNG ADULT;

EID: 80955177109     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.04.004     Document Type: Article

References (40)

1. Adam E.K., Doane L.D., Zinbarg R.E., Mineka S., Craske M.G., Griffith J.W. Prospective prediction of major depressive disorder from cortisol awakening responses in adolescence. Psychoneuroendocrinology 2010.
2. Amato M.P., Ponziani G., Rossi F., Liedl C.L., Stefanile C., Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult. Scler. 2001, 7(5):340-344.
3. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
4. Buchanan T.W., Kern S., Allen J.S., Tranel D., Kirschbaum C. Circadian regulation of cortisol after hippocampal damage in humans. Biol. Psychiatry 2004, 56(9):651-656.
5. Chida Y., Steptoe A. Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biol. Psychol. 2009, 80(3):265-278.
6. Chwastiak L., Ehde D.M., Gibbons L.E., Sullivan M., Bowen J.D., Kraft G.H. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am. J. Psychiatry 2002, 159(11):1862-1868.
7. Compston A., Coles A. Multiple sclerosis. Lancet 2002, 359(9313):1221-1231.
8. del Rey A., Besedovsky H.O. The cytokine-HPA axis circuit contributes to prevent or moderate autoimmune processes. Z. Rheumatol. 2000, 59(Suppl. 2). II/31-35.
9. del Rey A., Klusman I., Besedovsky H.O. Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1. Am. J. Physiol. 1998, 275(4 Pt. 2):R1146-R1151.
10. Ehlert U., Gaab J., Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol. Psychol. 2001, 57(1-3):141-152.
11. Erkut Z.A., Hofman M.A., Ravid R., Swaab D.F. Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. J. Neuroimmunol. 1995, 62(1):27-33.
12. Fassbender K., Schmidt R., Mossner R., Kischka U., Kuhnen J., Schwartz A., et al. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch. Neurol. 1998, 55(1):66-72.
13. Federenko I., Wust S., Hellhammer D.H., Dechoux R., Kumsta R., Kirschbaum C. Free cortisol awakening responses are influenced by awakening time. Psychoneuroendocrinology 2004, 29(2):174-184.
14. Fries E., Dettenborn L., Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int. J. Psychophysiol. 2009, 72(1):67-73.
15. Gay M.C., Vrignaud P., Garitte C., Meunier C. Predictors of depression in multiple sclerosis patients. Acta Neurol. Scand. 2010, 121(3):161-170.
16. Gold S.M., Mohr D.C., Huitinga I., Flachenecker P., Sternberg E.M., Heesen C. The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol. 2005, 26(12):644-652.
17. Gold S.M., Raji A., Huitinga I., Wiedemann K., Schulz K.H., Heesen C. Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis. J. Neuroimmunol. 2005, 165(1-2):186-191.
18. Grasser A., Moller A., Backmund H., Yassouridis A., Holsboer F. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp. Clin. Endocrinol. Diabetes 1996, 104(1):31-37.
19. Heesen C., Gold S.M., Huitinga I., Reul J.M. Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis-a review. Psychoneuroendocrinology 2007, 32(6):604-618.
20. Kahl K.G., Kruse N., Faller H., Weiss H., Rieckmann P. Expression of tumor necrosis factor-alpha and interferon-gamma mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis. Psychoneuroendocrinology 2002, 27(6):671-681.
21. Kern S., Oakes T.R., Stone C.K., McAuliff E.M., Kirschbaum C., Davidson R.J. Glucose metabolic changes in the prefrontal cortex are associated with HPA axis response to a psychosocial stressor. Psychoneuroendocrinology 2008, 33(4):517-529.
22. Kern S., Schrempf W., Schneider H., Schultheiss T., Reichmann H., Ziemssen T. Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis. Mult. Scler. 2009, 15(6):752-758.
23. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33(11):1444-1452.
24. MacPhee I.A., Antoni F.A., Mason D.W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 1989, 169(2):431-445.
25. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50(1):121-127.
26. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65(9):732-741.
27. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the " McDonald Criteria" Ann. Neurol. 2005, 58(6):840-846.
28. Pruessner J.C., Dedovic K., Khalili-Mahani N., Engert V., Pruessner M., Buss C., et al. Deactivation of the limbic system during acute psychosocial stress: evidence from positron emission tomography and functional magnetic resonance imaging studies. Biol. Psychiatry 2008, 63(2):234-240.
29. Pruessner J.C., Kirschbaum C., Meinlschmid G., Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28(7):916-931.
30. Pruessner M., Hellhammer D.H., Pruessner J.C., Lupien S.J. Self-reported depressive symptoms and stress levels in healthy young men: associations with the cortisol response to awakening. Psychosom. Med. 2003, 65(1):92-99.
31. Sadovnick A.D., Remick R.A., Allen J., Swartz E., Yee I.M., Eisen K., et al. Depression and multiple sclerosis. Neurology 1996, 46(3):628-632.
32. The Goldman Consensus statement on depression in multiple sclerosis, 2005. Mult. Scler. 11(3), 328-337.
33. Then Bergh F., Kumpfel T., Trenkwalder C., Rupprecht R., Holsboer F. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology 1999, 53(4):772-777.
34. Vinberg M., Bennike B., Kyvik K.O., Andersen P.K., Kessing L.V. Salivary cortisol in unaffected twins discordant for affective disorder. Psychiatry Res. 2008, 161(3):292-301.
35. Vreeburg S.A., Hoogendijk W.J., van Pelt J., Derijk R.H., Verhagen J.C., van Dyck R., et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch. Gen. Psychiatry 2009, 66(6):617-626.
36. Wei T., Lightman S.L. The neuroendocrine axis in patients with multiple sclerosis. Brain 1997, 120(Pt. 6):1067-1076.
37. Weinstein A.A., Deuster P.A., Francis J.L., Bonsall R.W., Tracy R.P., Kop W.J. Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression. Biol. Psychol. 2010, 84(2):228-234.
38. Wichers M.C., Myin-Germeys I., Jacobs N., Kenis G., Derom C., Vlietinck R., et al. Susceptibility to depression expressed as alterations in cortisol day curve: a cross-twin, cross-trait study. Psychosom. Med. 2008, 70(3):314-318.
39. Wust S., Federenko I., Hellhammer D.H., Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000, 25(7):707-720.
40. Ysrraelit M.C., Gaitan M.I., Lopez A.S., Correale J. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 2008, 71(24):1948-1954.